Market Indices
Latest News
 |
| ||
| ||
| ||
|
Price Targets
from Northland Securities issued a price target of $70.00 for VEON on 2026-06-09 11:07:21.The adjusted price target was set to $70.00.At the time of the announcement, VEON...
June 9, 2026 VEON 0.53%
from CLSA issued a price target of $6.10 for MLCO on 2026-06-05 13:29:13.The adjusted price target was set to $6.10.At the time of the announcement, MLCO was...
June 5, 2026 MLCO -5.55%
Market Movers
| Top Gainers (%) | |||||||||||||||||||
| FRSX Foresight Autonomous Hold | 1.67
19.29% | ||||||||||||||||||
| ADXN Addex Therapeutics Ltd | 6.79
15.87% | ||||||||||||||||||
| LXEH Lixiang Education Holding | 1.37
13.22% | ||||||||||||||||||
| JFU 9F Inc. | 3.09
10.36% | ||||||||||||||||||
| ATHE Alterity Therapeutics Lim | 4.29
9.44% | ||||||||||||||||||
| TC Token Cat Limited | 9.34
8.35% | ||||||||||||||||||
| IXHL Incannex Healthcare Limit | 3.67
7.94% | ||||||||||||||||||
| AKO-A Embotelladora Andina S.A. | 21.90
7.93% | ||||||||||||||||||
Annual/Quarterly Reports Summary
Summit Therapeutics Inc. (SMMT) Quarterly Report: What Does It Reveal About Their Sector Performance
May 1, 2025 SMMT 1.28%
In a landscape of rising revenues and increasing operational costs, the company navigates challenges with a focus on innovation and sustainability. Despite a dip in net income and profit declines...
February 5, 2025 TEVA 3.58%
In a year marked by resilience, the company celebrated record revenues of $25 billion, driven by strong ticket sales and operational efficiency. With a focus on North America, it reduced...
January 27, 2025 TEVA 3.58%